Enalapril Attenuates Downregulation of Angiotensin-Converting Enzyme 2 in the Late Phase of Ventricular Dysfunction in Myocardial Infarcted Rat

Hypertension - United States
doi 10.1161/01.hyp.0000237862.94083.45
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Angiotensin-Converting Enzyme 2 Inhibits High-Mobility Group Box 1 and Attenuates Cardiac Dysfunction Post-Myocardial Ischemia

Journal of Molecular Medicine
Molecular MedicineDrug DiscoveryGenetics
2015English

Candesartan Ameliorates Cardiac Dysfunction Observed in Angiotensin-Converting Enzyme 2-Deficient Mice

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2008English

Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors

Hypertension
Internal Medicine
2004English

Murine Recombinant Angiotensin-Converting Enzyme 2: Effect on Angiotensin II-Dependent Hypertension and Distinctive Angiotensin-Converting Enzyme 2 Inhibitor Characteristics on Rodent and Human Angiotensin-Converting Enzyme 2

Hypertension
Internal Medicine
2012English

Angiotensin-Converting Enzyme 2 (ACE2) in Disease Pathogenesis

Circulation Journal
MedicineCardiovascular MedicineCardiology
2010English

Vascular Angiotensin-Converting Enzyme 2: Lord of the Ring?

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2010English

Converting Enzyme Inhibition and Renal Tissue Angiotensin II in the Rat

Hypertension
Internal Medicine
1994English

Characterization of Renal Angiotensin-Converting Enzyme 2 in Diabetic Nephropathy

Hypertension
Internal Medicine
2003English

Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload-Induced Cardiac Dysfunction by Increasing Local Angiotensin II

Hypertension
Internal Medicine
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy